BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 323539)

  • 1. [Treatment for sepsis in hematological diseases with combined large-dosage antibiotics of two different groups, with special reference to the relation between clinical effects and drug-sensitivity of causative organisms (author's transl)].
    Yoshikawa H; Ohno R; Kawashima K; Ueda R; Takeyama H
    Rinsho Ketsueki; 1977 Feb; 18(2):110-7. PubMed ID: 323539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacteremia and sepsis caused by Escherichia coli and other gram negative bacilli].
    Falisevac J; Schönwald S; Car V
    Lijec Vjesn; 1970; 92(2):149-67. PubMed ID: 4919347
    [No Abstract]   [Full Text] [Related]  

  • 3. Tobramycin: clinical and microbiological evaluation.
    Schoutens E; Vanderlinden MP; Yourassowsky E
    Int J Clin Pharmacol; 1973 Nov; 8(3):207-15. PubMed ID: 4589328
    [No Abstract]   [Full Text] [Related]  

  • 4. [The bacterial infections in patients with acute leukemia and their treatment by antibiotics, with special reference to Klebsiella and Pseudomonas infections (author's transl)].
    Yoshikawa H; Ono R; Koie K; Imai K; Kamiya T
    Rinsho Ketsueki; 1975 Jul; 16(7):709-15. PubMed ID: 1236974
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program.
    Bhavnani SM; Ambrose PG; Craig WA; Dudley MN; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):231-6. PubMed ID: 16423491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopotentiation in infectious disease, II. Effect of bestatin on experimental infection.
    Ormrod DJ; Clarke IA; Miller TE
    Chemioterapia; 1985 Aug; 4(4):324-8. PubMed ID: 3902258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New antibiotics].
    Hitzenberger G
    Wien Med Wochenschr; 1979 Jul; 129(14):383-6. PubMed ID: 388886
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-trimoxazole in cases of gram-negative septicaemia.
    Brandberg A
    Scand J Infect Dis Suppl; 1976; (8):96-102. PubMed ID: 819991
    [No Abstract]   [Full Text] [Related]  

  • 9. Gentamicin in the treatment of sepsis in newborn infants.
    Elfving J; Pettay O
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:124-. PubMed ID: 4591708
    [No Abstract]   [Full Text] [Related]  

  • 10. Colistin for Klebsiella pneumoniae-associated sepsis.
    Karabinis A; Paramythiotou E; Mylona-Petropoulou D; Kalogeromitros A; Katsarelis N; Kontopidou F; Poularas I; Malamou-Lada H
    Clin Infect Dis; 2004 Jan; 38(1):e7-9. PubMed ID: 14679468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic resistance and plasmid profile of E. coli and Klebsiella strains isolated from hospitalized patients under prolonged antibiotic therapy].
    Milch H; László V; Tóth I; Czirók E; Arr M; Magyar T; Gráber H
    Orv Hetil; 1986 Nov; 127(47):2857-63. PubMed ID: 3540782
    [No Abstract]   [Full Text] [Related]  

  • 12. Meropenem in neonates.
    Nair PM
    Indian Pediatr; 2005 Sep; 42(9):963. PubMed ID: 16208069
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial of cefoxitin (mefoxin) in parenteral therapy of septicemia (postabortal and postpartum) in Ibadan.
    Adelusi B; Osoba AO; Adetoro OA; Ojengbede AO; Adeyemi-Doro FA; Rotowa NA
    Afr J Med Med Sci; 1985; 14(1-2):31-5. PubMed ID: 2994436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An empirical combination of antibiotics used in aplasias during chemotherapy for acute malignant hemopathies (author's transl)].
    Fiere D; Vuvan H; Guyotat D; Ffrench M; Gonnaud P; Extra JM; Imbert C; Coiffier B; Bryon PA; Rebattu P; Viala JJ
    Sem Hop; 1982 Jan; 58(3):139-42. PubMed ID: 6278619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adreno-corticosteroids in the treatment of bacterial sepsis: a double-blind study with pharmacological doses.
    Klastersky J; Capel R
    Antimicrob Agents Chemother (Bethesda); 1970; 10():175-80. PubMed ID: 4939732
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of septicemia due to gram negative bacilli (salmonellosis excluded)].
    Rapin M; Le Gall JR
    Anesth Analg (Paris); 1971; 28(4):753-9. PubMed ID: 4947910
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigations on the aetiology and antibiotic management of neonatal septicemia.
    Monintja HE
    Paediatr Indones; 1988; 28(5-6):105-15. PubMed ID: 3078030
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
    Kotapati S; Kuti JL; Nightingale CH; Nicolau DP
    J Infect; 2005 Oct; 51(3):211-7. PubMed ID: 16230218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of underlying disease in patients with gram-negative bacteremia.
    Freid MA; Vosti KL
    Arch Intern Med; 1968 May; 121(5):418-23. PubMed ID: 4871700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.